Brief: C4 Therapeutics Announces 2024 Priorities And Extended Cash Runway

C4 Therapeutics

09/01/2024 22:23

Jan 9 (Reuters) - C4 Therapeutics Inc  CCCC.O :
    * C4 THERAPEUTICS ANNOUNCES 2024 PRIORITIES AND EXTENDED
CASH
RUNWAY TO ADVANCE PORTFOLIO OF TARGETED PROTEIN DEGRADATION
MEDICINES
    * C4 THERAPEUTICS INC - CASH RUNWAY INTO 2027
    * C4 THERAPEUTICS INC - C4T IS RESTRUCTURING ITS OPERATIONS
AND
REDUCING ITS WORKFORCE BY APPROXIMATELY 30%
    * C4 THERAPEUTICS INC - UNAUDITED CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES AS OF JANUARY 5, 2024 WERE APPROXIMATELY
$330 MILLION

Source text for Eikon:  ID:nGNX3zFf27 
Further company coverage:  CCCC.O 

 ((Reuters.Briefs@thomsonreuters.com;))